Yongde Liao, PhD, MD (Thoracic Surgery)
Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Dr. Liao obtained his Medical Doctor degree from the German Cancer Research Centre in 2003, and now is a professor and doctoral supervisor of Department of Thoracic Surgery, Tongji Hospital, Wuhan. He has been engaged in clinical and research of thoracic surgery for more than 20 years.
His main researches are focused on thoracic surgery, especially thoracic malignancies. Dr. Liao has studied at the prestigious Heidelberg University in Europe for many years. Long-term commitment to the diagnosis and treatment of lung cancer, esophageal cancer, mediastinal tumors and other chest diseases, he has created a systematic, standardized, internationally advanced and effective diagnosis and treatment methods, short-term and long-term results were excellent. Surgery can completely remove the lesion and maximize the quality of life. He is good at formulating and implementing effective individualized solutions for each patient's condition and psychology. Establish complete files for all patients and follow up long-term guidance.
Dr. Liao has made a great success as an outstanding clinician. With an annual operation volume of more than 500, 70% of the patients underwent minimally invasive thoracoscopic surgery. Left central lung cancer, autologous bronchial valvuloplasty instead of sleeve resection, and a series of innovative procedures were published in the top international Thoracic Surgery Journal (ATS / JTCVS). Notably, he published an article of “Laparoscopic and thoracoscopic esophagectomy with intrathoracic anastomosis for middle or lower esophageal carcinoma”, the technique reported is safe, feasible and user-friendly. Moreover, he has presented clinical research results in international conferences.
Basic research has long been devoted to exploring the mechanism and therapeutic application of estrogen in lung cancer, and a series of studies have been supported by the National Natural Science Foundation of China. More than 20 SCI papers have been published. A number of clinical trials have been carried out or are being prepared. A number of innovative studies are under way. It is the most active and influential research team in this field in China.
Articles Published in the Journal of Thoracic Disease